Infectious Diseases

Vaccine Development

Vaccines remain one of the most effective tools for preventing infectious diseases. From smallpox eradication to the rapid deployment of COVID-19 vaccines, immunization has saved millions of lives. Today, researchers are leveraging technologies such as mRNA platforms, viral vectors, and protein subunits to develop faster, more adaptable vaccines against emerging and re-emerging pathogens. However, challenges remain—vaccine hesitancy, equitable distribution, cold chain logistics, and rapid variant evolution. This congress will feature discussions on the latest advances in vaccine science, including universal influenza vaccines, RSV immunization, and next-gen delivery systems. Experts will also explore policy frameworks for regulatory approval, public communication strategies, and pandemic-scale production. Attendees will gain insights into overcoming scientific, logistical, and societal hurdles to accelerate vaccine innovation and global coverage.